Sotera Health Announces Fourth Quarter and Full Year 2021 Earnings Release Date
CLEVELAND, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization...
News
Nephros Fourth Quarter 2021 Financial Results Conference Call
SOUTH ORANGE, NJ, Feb. 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and...
Crinetics Pharmaceuticals to Participate in SVB Leerink Global Healthcare Conference
SAN DIEGO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery,...
Humacyte to Participate in Fireside Chat at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
DURHAM, N.C., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable...
Harpoon Therapeutics to Participate in SVB Leerink Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing...
BioCryst to Report Fourth Quarter 2021 Financial Results on February 23
RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company...
Pardes Biosciences to Host Virtual Investor Event
Company to host conference call and webcast at 3 p.m. PT on Tuesday, February 15, 2022CARLSBAD, Calif., Feb. 09, 2022...
Atea Pharmaceuticals to Present at 11th Annual SVB Leerink Global Healthcare Conference
BOSTON, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the...
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
• FDA Agreed to PolyPid Request for the Addition of an Unblinded Interim Analysis in SHIELD I once 750 Patients...
BioXcel Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
NEW HAVEN, Conn., Feb. 09, 2022 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial...
Cogent Biosciences to Present at 11th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass. and BOULDER, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...
Psyence Group Announces DTC Eligibility Approval in the U.S.
TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...
IGM Biosciences Advances Novel Antibody IGM-6268 Into Clinical Trials for the Treatment and Prevention of COVID-19
– In vitro studies indicate IGM-6268 exhibits potent neutralization activity against the Omicron variant and all other Variants of Concern and Variants...
Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference
SAN DIEGO and TAICANG, China, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or...
ONL Therapeutics Appoints Sushanta Mallick as Chief Development Officer
ANN ARBOR, Mich., Feb. 09, 2022 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for...
SweetWater Brewing Company Expands Distribution Across California
11th Largest Craft Brewer in the U.S., SweetWater, Launches Partnership with the Country’s Largest Beer Distributor, Reyes Beer Division West...
HOOKIPA to Present at the SVB Leerink Global Healthcare Conference
NEW YORK and VIENNA, Austria, Feb. 09, 2022 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing...
Medicenna Reports Third Quarter Fiscal 2022 Financial Results and Operational Highlights
-- Phase 1/2 ABILITY study of MDNA11 on track with first set of efficacy results from early dose escalation cohorts...
Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 First Quarter Financial Results
Company to host a webcast today at 4:30 p.m. Eastern Time NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences...
TCR² Therapeutics to Present at the SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a...
